http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017141272-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_114e4423ec77cbc8dab9d0a98909704e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-695 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F7-0816 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P33-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-695 |
| filingDate | 2017-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b5db55a1de649e255fd3f3fe56c45469 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d98224611e0ef3a9139ebd480ece95d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_528f0312532f76fdd28c82b81cbc1f8d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26cf40eaf4b48614aef6c4e7659eb0e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f60be10f37101348a2402cd69477a2 |
| publicationDate | 2017-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2017141272-A1 |
| titleOfInvention | Silicon based cyclic compounds and pharmaceutical compositions for treating malaria and toxoplasmosis |
| abstract | The present invention discloses novel silicon incorporated cyclic compounds of formula I, Wherein Ar 1 and Ar 2 are individually selected from any aryl group which can be optionally substituted; X is selected from any inorganic anion such as halide, carbonate, sulfate, nitrate or any organic anion selected from acetate, tartarate, citrate, carbonate or organosulfonates such as tosylate, mesylate, triflate; R 1 and R 2 are individually selected from C1-C8 alkyl, cycloalkyl, aryl, heteroaryl, aralkyl, alkoxyalkyl, aminoalkyl, thioalkyl, haloalkyl or hydroxyalkyl. R 1 and R 2 together may form a ring which optionally may be substituted or may contain heteroatoms; a pharmaceutical composition comprising a therapeutically effective amount of compounds of general formula I, including geometrical isomers and/or salts thereof along with a drug and optionally along with a carrier or diluent or pharmaceutically acceptable excipient for treating malaria and toxoplasmosis. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10562922-B2 |
| priorityDate | 2016-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 256.